Human stem cells may produce 'artificial blood'
Scientists are using stem cells to create artificial blood that will be tested in the UK in two years. The scientists that are doing the research believe it could change the way blood transfusions are performed, preventing hospitals from running out of blood and saving thousands of lives from battlefield and car accidents. Heart transplants, bypass surgery and cancer patients also can be benefited from it, ensuring they have an adequate blood supply during surgery.
This kind of artificial blood can avoid infectious diseases. It can provide blood for almost everyone with different blood types. Researchers at the university of Edinburgh and the university of Bristol have given hope of life to many people by growing billions of red blood cells from stem cells taken from bone marrow for the first time. But regular transfusions typically contain 2.5 trillion red blood cells, so they do not currently grow enough to meet the need. Materials taken from human embryos in the first few days of life are more likely to split into large Numbers of cells, but so far researchers have not succeeded in producing real blood.
If scientists eventually find a way to make real blood, theoretically, it could just take one embryo to supply all the cells that Britain needs for its blood supply. Prof Marco Stern, who is from the university of Edinburgh, wants to create a cell supply of o-negative blood. This "universal donor" could meet the need for blood up to 98% of the population. He plans to inject a teaspoon of artificial blood into healthy volunteers within two to three years, doing his first experiment with blood made from stem cells in United Kingdom.
- May 16, 2019Researchers have demonstrated that neurons from human embryonic stem cells (hESCs) can be functionally integrated in the brains of living mice, a key step toward successful cell transplantation therap...view
- November 27, 2018One of the preconditions for successful treatment of brain cancer with T cell immunotherapy is that engineered T cells can enter brain tissues and contact cancer cells, but clinical experiments and ba...view
- May 16, 2019Professor shinya yamanaka, director of the institute of Induced Pluripotent Stem Cells (ips) at Kyoto university, and his team have discovered the Glis1 gene that is an important component of the Indu...view